Early-stage drug development worldwide has nearly doubled over the past decade and shifted from a U.S.-dominated model to a dual hub centered in the United States and China, according to new research ...

The pharmaceutical industry is experiencing its own “DeepSeek moment,” according to science writer Hiya Jain. Just as the upstart AI breakthrough caught Silicon Valley off-guard, China is emerging as ...

At the American Association for Cancer Research (AACR) Annual Meeting, the spotlight often reflects the rapid pace of cancer science: new targets, emerging biology, and evolving therapeutic approaches ...

Clinical research has transformed childhood cancer survival in the past 50 years. Cooperative group trials have tailored therapy according to risk stratification, with overall survival across all ...

Drug development is among the slowest, most failure-prone processes in modern science, with about 90% of drug candidates ...

The FDA announced a series of measures Monday to accelerate drug development, including a pilot program designed to shorten the time it takes to move a drug from identification to first-in-human ...

Insilico Medicine, a clinical-stage biotechnology company powered by generative artificial intelligence (AI), today announced advancements to its unified AI framework for drug target discovery, ...

Continuous process improvement can benefit all aspects of life — from personal New Year’s resolutions to complex drug development. In a world where two-thirds of planned improvement initiatives fail, ...

This article summarizes a discussion at LSX Biopharm America on September 11. A panel of industry experts discussed approaches to overcoming the most urgent CMC challenges during the discussion. The ...

This episode of the Pharmaron DMPK Insights Podcast Series sees Simon Taylor (Vice President of Drug Discovery at Pharmaron) and Dr. Emile Chen (former Director of Modeling and Translational Biology ...